404 related articles for article (PubMed ID: 29133107)
1. Paraneoplastic neuromyelitis optica spectrum disorder: A case report and review of the literature.
Annus Á; Bencsik K; Obál I; Kincses ZT; Tiszlavicz L; Höftberger R; Vécsei L
J Clin Neurosci; 2018 Feb; 48():7-10. PubMed ID: 29133107
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.
Sepúlveda M; Sola-Valls N; Escudero D; Rojc B; Barón M; Hernández-Echebarría L; Gómez B; Dalmau J; Saiz A; Graus F
Mult Scler; 2018 Nov; 24(13):1753-1759. PubMed ID: 28920766
[TBL] [Abstract][Full Text] [Related]
3. Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder associated with esophageal cancer.
Kon T; Ueno T; Suzuki C; Nunomura J; Igarashi S; Sato T; Tomiyama M
J Neuroimmunol; 2017 Aug; 309():38-40. PubMed ID: 28601284
[TBL] [Abstract][Full Text] [Related]
4. A case of seropositive Neuromyelitis Optica in a paediatric patient with co-existing acute nephrotic syndrome.
Volkman T; Hemingway C
Mult Scler Relat Disord; 2017 Nov; 18():103-105. PubMed ID: 29141789
[TBL] [Abstract][Full Text] [Related]
5. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic neuromyelitis optica spectrum disorders: a case series.
Virgilio E; Vecchio D; Vercellino M; Naldi P; Tesser F; Cantello R; Cavalla P; Comi C
Neurol Sci; 2021 Jun; 42(6):2519-2522. PubMed ID: 33506301
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
8. Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report.
Bejerot S; Hesselmark E; Mobarrez F; Wallén H; Hietala MA; Nybom R; Wetterberg L
J Med Case Rep; 2019 Jan; 13(1):27. PubMed ID: 30696485
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A Rare Case of Advanced Breast Cancer with Intractable Nausea and Vomiting.
Miyagishima D; Anezaki T; Fukuda A; Watanabe H; Hata M; Eguchi M
Am J Case Rep; 2023 Nov; 24():e941808. PubMed ID: 37933098
[TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation.
Beauchemin P; Iorio R; Traboulsee AL; Field T; Tinker AV; Carruthers RL
Mult Scler Relat Disord; 2018 Feb; 20():37-42. PubMed ID: 29291482
[TBL] [Abstract][Full Text] [Related]
12. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
[TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
[TBL] [Abstract][Full Text] [Related]
15. Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
Wang JY; Wang K; Chen XW; Wang JW; Zhang K; Xu MW; Luo BY
Mult Scler; 2013 Apr; 19(5):639-43. PubMed ID: 23069875
[TBL] [Abstract][Full Text] [Related]
16. Screening for onconeural antibodies in neuromyelitis optica spectrum disorders.
Berger B; Hottenrott T; Rauer S; Stich O
BMC Neurol; 2017 Jan; 17(1):5. PubMed ID: 28068933
[TBL] [Abstract][Full Text] [Related]
17. A case of paraneoplastic neuromyelitis optica associated with small cell lung carcinoma.
Deuel LM; Bunch ME
J Neuroimmunol; 2018 Mar; 316():130-132. PubMed ID: 29317098
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report.
Narumi Y; Yoshida R; Minami Y; Yamamoto Y; Takeguchi S; Kano K; Takahashi K; Saito T; Sawada J; Terui H; Katayama T; Sasaki T; Ohsaki Y
BMC Cancer; 2018 Jan; 18(1):95. PubMed ID: 29361915
[TBL] [Abstract][Full Text] [Related]
19. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature.
Cai G; He D; Chu L; Dai Q; Xu Z; Zhang Y
Int J Neurosci; 2016; 126(7):660-8. PubMed ID: 26010208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
